Sagimet Total Assets vs Capital Stock Analysis
| SGMT Stock | 5.36 0.33 5.80% |
Sagimet Biosciences financial indicator trend analysis is much more than just breaking down Sagimet Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sagimet Biosciences is a good investment. Please check the relationship between Sagimet Biosciences Total Assets and its Capital Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sagimet Biosciences Series. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Total Assets vs Capital Stock
Total Assets vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sagimet Biosciences Total Assets account and Capital Stock. At this time, the significance of the direction appears to have strong relationship.
The correlation between Sagimet Biosciences' Total Assets and Capital Stock is 0.74. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Capital Stock in the same time period over historical financial statements of Sagimet Biosciences Series, assuming nothing else is changed. The correlation between historical values of Sagimet Biosciences' Total Assets and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Sagimet Biosciences Series are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Total Assets i.e., Sagimet Biosciences' Total Assets and Capital Stock go up and down completely randomly.
Correlation Coefficient | 0.74 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of Sagimet Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Sagimet Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.Most indicators from Sagimet Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sagimet Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sagimet Biosciences Series. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Sagimet Biosciences' Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.63 in 2024, despite the fact that Enterprise Value is likely to grow to (17.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 26K | 553K | 1.7M | 1.8M | Net Interest Income | 26K | 553K | 1.7M | 1.8M |
Sagimet Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Sagimet Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.